Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-02-14

FDA Approved: FYCOMPA — Supplemental Application (Eisai Inc.)

View source ↗

Summary

The FDA approved Eisai Inc.'s supplemental application for FYCOMPA (perampanel).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fycompa (perampanel)

Snippet

SUPPL AP for FYCOMPA (PERAMPANEL)